EUVIMEDEUVIMED entdecken
Crossref

Quality by Design Assisted Development and Characterization of Dexibuprofen-Loaded Microspheres for Controlled Drug Release

Makeshwar PE, Sangeetha G, Girinath M, Guna Shree A, MC Likith

International Journal of Drug Delivery Technology · 08.04.2026 · 16 (03)

DOI: 10.25258/ijddt.16.3.83 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.04.2026. Verfasst von Makeshwar PE und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Dexibuprofen, a nonsteroidal anti-inflammatory drug, is widely used for the management of pain and inflammation. However, its clinical use is associated with gastrointestinal adverse effects such as irritation, ulceration, and bleeding, along with the need for frequent dosing at higher concentrations. To address these limitations, dexibuprofen was formulated into microspheres to achieve controlled drug release using a Quality by Design approach.

Methods

Dexibuprofen-loaded microspheres were prepared using the emulsion solvent evaporation method. The formulation was optimized using a full factorial design, considering three factors: PLGA concentration, PVA concentration, and stirring speed, and three responses: particle size, % encapsulation efficiency, and % in vitro drug release. A total of ten formulations were generated based on the experimental design. The optimized microsphere formulation was further evaluated for drug content, zeta potential, in vitro drug release kinetics, surface morphology using scanning electron microscopy, analgesic activity, and stability studies.

Results

The microspheres were optimised numerically using the global desirability value of 0.878. The optimised dexibuprofen microspheres were found to have a particle size of 495.5 nm, entrapment efficiency of 91.65%, % in vitro drug release of 88.91%, drug content of 90.8%, and zeta potential of -26.3 mV. The release kinetics confirmed that it follows the zero-order kinetics with an R² value of 0.9884. The optimised microspheres showed an analgesic activity in the test group for over 12 h, confirming the controlled release of the drug. The SEM demonstrated that the produced microspheres were spherical.

Conclusion

The optimized microsphere formulation exhibited sustained drug release and effective analgesic activity, indicating its potential to enhance therapeutic efficacy while minimizing the gastrointestinal side effects of conventional dexibuprofen.

Zitieren

APA

PE, M., G, S., M, G., A, G. S., & Likith, M. (2026). Quality by Design Assisted Development and Characterization of Dexibuprofen-Loaded Microspheres for Controlled Drug Release. International Journal of Drug Delivery Technology, 16(03). https://doi.org/10.25258/ijddt.16.3.83

Vancouver

PE M, G S, M G, A GS, Likith M. Quality by Design Assisted Development and Characterization of Dexibuprofen-Loaded Microspheres for Controlled Drug Release. International Journal of Drug Delivery Technology. 2026;16(03). doi:10.25258/ijddt.16.3.83

BibTeX
@article{PE2026,
  author = {PE, Makeshwar and G, Sangeetha and M, Girinath and A, Guna Shree and Likith, MC},
  title = {Quality by Design Assisted Development and Characterization of Dexibuprofen-Loaded Microspheres for Controlled Drug Release},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {03},
  doi = {10.25258/ijddt.16.3.83}
}
Kostenlos starten →